Shariah compliance overview
Not HalalAkari Therapeutics, Plc (AKTX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Akari Therapeutics, Plc
Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing.
Akari Therapeutics, Plc (AKTX) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing debt, Interest-bearing securities and assets.
- Business Activity
- 100.00%Limit 5%Fail
- Interest-bearing debt
- 162.59%Limit 30%Fail
- Interest-bearing securities and assets
- 1121.96%Limit 30%Fail
- Dividend purification
- 100.00%Share of dividends to give to charityPurification calculator
Last updated: Oct 23, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Akari Therapeutics, Plc (AKTX). Current Akinda screening label: Not Halal.
